Correspondence 0001213900-24-078897 from Altamira Therapeutics Ltd. (CYTO) (CIK 0001601936) (CYTOF)
Altamira Therapeutics Ltd. (CYTO) (CIK 0001601936)
Date: Sept. 16, 2024 · CIK: 0001601936 · Accession: 0001213900-24-078897
AI Filing Summary & Sentiment
File numbers found in text: 333-281724
Letter
Re:
September 16, 2024
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Washington, DC 20549
Altamira Therapeutics Ltd.
Registration Statement on Form F-1 (File No. 333-281724), as amended – Concurrence in Acceleration Request
Ladies and Gentlemen:
H.C. Wainwright & Co., LLC (“Wainwright”), solely acting as placement agent on a best efforts basis in an offering pursuant to the registration statement on Form F-1 (File No. 333-281724) (the “Registration Statement”), hereby concurs in the request by Altamira Therapeutics Ltd. that the effective date of the above-referenced registration statement be accelerated to 5:15 P.M. (Eastern Time), or as soon as practicable thereafter, on September 16, 2024, pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”). Wainwright affirms that it is aware of its obligations under the Securities Act as they pertain to the best efforts offering pursuant to the Registration Statement.
Very truly yours,
H.C. WAINWRIGHT & CO., LLC
Show Raw Text
CORRESP
1
filename1.htm
September 16, 2024
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Washington, DC 20549
Re:
Altamira Therapeutics Ltd.
Registration Statement on Form F-1 (File No. 333-281724), as amended
– Concurrence in Acceleration Request
Ladies and Gentlemen:
H.C. Wainwright & Co., LLC
(“Wainwright”), solely acting as placement agent on a best efforts basis in an offering pursuant to the registration
statement on Form F-1 (File No. 333-281724) (the “Registration Statement”), hereby concurs in the request by Altamira
Therapeutics Ltd. that the effective date of the above-referenced registration statement be accelerated to 5:15 P.M. (Eastern Time), or
as soon as practicable thereafter, on September 16, 2024, pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Securities
Act”). Wainwright affirms that it is aware of its obligations under the Securities Act as they pertain to the best efforts offering
pursuant to the Registration Statement.
Very truly yours,
H.C. WAINWRIGHT & CO., LLC
By:
/s/ Edward D. Silvera
Name:
Edward D. Silvera
Title:
Chief Operating Officer